Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

717
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
717
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

209
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
209
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

26
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
26
Angina IV: Management01:26

Angina IV: Management

12
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

22
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
22

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial Atherosclerosis: Vascular Surgery Interventions.

American family physician·2022
Same author

Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.

American family physician·2020
Same author

Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment.

American family physician·2019
Same author

CV risk prediction tools: Imperfect, Yes, but are they serviceable?

The Journal of family practice·2018
Same author

Newer cholesterol-lowering agents: What you must know.

The Journal of family practice·2018
Same author

Estimating Cardiovascular Risk.

American family physician·2017

Related Experiment Video

Updated: Aug 2, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.1K

Hyperlipidemia management: A calibrated approach.

Jonathon M Firnhaber1

  • 1Department of Family Medicine, Brody School of Medicine, East Carolina University, Greenville, NC.

The Journal of Family Practice
|April 19, 2023
PubMed
Summary

This study measures LDL cholesterol levels and identifies Atherosclerotic Cardiovascular Disease (ASCVD) risk factors. These findings guide medical therapy for primary and secondary prevention strategies.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Lipid Metabolism

Background:

  • Elevated low-density lipoprotein (LDL) cholesterol is a primary driver of Atherosclerotic Cardiovascular Disease (ASCVD).
  • Accurate risk assessment is crucial for effective cardiovascular disease prevention strategies.

Purpose of the Study:

  • To evaluate the measurement of LDL cholesterol levels.
  • To assess additional risk-enhancing factors for ASCVD beyond LDL cholesterol.
  • To inform the initiation of medical therapy for primary and secondary ASCVD prevention.

Main Methods:

  • Utilizing established laboratory assays to quantify LDL cholesterol.
  • Systematic review and analysis of clinical data for recognized ASCVD risk-enhancing factors.
  • Integration of LDL cholesterol levels and risk factors into established risk prediction models.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K

Related Experiment Videos

Last Updated: Aug 2, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.1K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K

Main Results:

  • Quantification of LDL cholesterol levels across diverse patient cohorts.
  • Identification and prevalence of key risk-enhancing factors contributing to ASCVD risk.
  • Demonstrated correlation between elevated LDL cholesterol, risk factors, and ASCVD incidence.

Conclusions:

  • Accurate LDL cholesterol measurement is fundamental for ASCVD risk stratification.
  • Incorporating risk-enhancing factors refines ASCVD risk assessment.
  • This comprehensive approach optimizes the selection of medical therapy for cardiovascular disease prevention.